Inari Stock
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.
Sign up today and learn more about Inari Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Inari Stock
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment. It embraces diversity in every aspect of its business to drive innovation and help build a new food system. The company's technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of the seed. Inari's SEEDesign platform is their point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach. It was founded in 2016 and is based in Cambridge, MA.
Investors
G Squared
Impossible Foods, Bolt, 23andMe, Convoy, Fair, Collective Health, Postmates, Blend, Getaround, Tipalti
K2 HealthVentures
Pavilion Capital
Rivas Capital
Funding History
August 2018 | $40.0M |
---|---|
August 2019 | $89.0M |
April 2020 | $45.0M |
May 2021 | $208M |
October 2022 | $124M |
Management
CEO and Director
Ponsi Trivisvavet
Chief Scientific Officer
Catherine Feuillet
General Counsel
Pierre-Etienne Boin
Sr. VP, People
Nora Dutta
SVP, Innovation Catalyst
Michael Kock
Board Member
Solange Bullukian
Board Member
Ignacio Martinez
Scientific Strategy Board Member
Jennifer Doudna
Member of the Board of Directors
Robert Berendes
Director
Howard W. Buffett
Executive Chairman
Michael Mack
Scientific Strategy Board Member
George Church
Board Member
Moon-Ghee Ryu
Director
Rob Rosiello
Chief Financial Officer
Stuart Brown
Co-Founder & Director
Ignacio Martinez
Board Member
Sophie Vandebroek
Director
Bob Bechek
Board Member
Ponsi Trivisvavet
Press
news - Feb, 7 2024
The 10 Biggest Rounds Of January: Generate Capital, Recurrent Energy Top First Month Of Yearinsideindianabusiness - Feb, 6 2024
Inari raises another $103M for gene-editing technologynews - Feb, 2 2024
The Week’s 10 Biggest Funding Rounds: Generate Capital Goes Big Again, Kore.ai Nabs $150Mglobalaginvesting - Feb, 1 2024
Inari Closes on $103M Series F For its SEEDesign™ Platformagfundernews - Feb, 1 2024
Seed gene-editing startup Inari valued at $165bn following $103m fundraise